NM
TCRR
Newtyn Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-1,015,920
| Closed | -$1.52M | – | 83 |
|
2023
Q1 | $1.52M | Sell |
1,015,920
-59,080
| -5% | -$88.6K | 0.3% | 53 |
|
2022
Q4 | $1.07M | Buy |
1,075,000
+475,000
| +79% | +$474K | 0.22% | 50 |
|
2022
Q3 | $1.08M | Sell |
600,000
-92,799
| -13% | -$167K | 0.24% | 52 |
|
2022
Q2 | $2.01M | Buy |
+692,799
| New | +$2.01M | 0.38% | 41 |
|